March 29th 2023
Among persons with prediabetes who reverted to normoglycemia, only those who remained physically active saw a reduced risk of all-cause death, study authors report.
March 27th 2023
Empagliflozin CKD Phase 3 Trial Stopped Early for Positive Efficacy Seen in Interim AssessmentMarch 22nd 2022
The phase 3 EMPA-KIDNEY clinical trial had just met prespecified criteria for positive efficacy when the study's Independent Data Monitoring Committee recommended the early halt.